BrainPepPass: A Framework Based on Supervised Dimensionality Reduction for Predicting Blood-Brain Barrier-Penetrating Peptides

被引:1
作者
de Oliveira, Ewerton Cristhian Lima [1 ,2 ]
Hirmz, Hannah [3 ]
Wynendaele, Evelien [3 ]
Feio, Juliana Auzier Seixas [1 ]
Moreira, Igor Matheus Souza [1 ]
da Costa, Kaue Santana [5 ]
Lima, Anderson H. [4 ]
De Spiegeleer, Bart [3 ]
de Sales Jr, Claudomiro de Souza [1 ]
机构
[1] Univ Fed Para, Lab Inteligencia Computac & Pesquisa Operac, Inst Tecnol, BR-66075110 Belem, Para, Brazil
[2] Inst Tecnol Vale, BR-66055090 Belem, Para, Brazil
[3] Univ Ghent, Fac Pharmaceut Sci, Drug Qual & Registrat DruQuaR Grp, B-9000 Ghent, Belgium
[4] Univ Fed Para, Lab Planejamento & Desenvolvimento Farmacos, Inst Ciencias Exatas & Nat, BR-66075110 Belem, Para, Brazil
[5] Univ Fed Oeste Para, Lab Simulacao Computac, BR-68040255 Santarem, Para, Brazil
关键词
CENTRAL-NERVOUS-SYSTEM; IN-SILICO PREDICTION; DRUG DISCOVERY; COMPUTATIONAL APPROACH; INSULIN TRANSPORT; SHUTTLE PEPTIDES; QSAR MODELS; PERMEABILITY; PERMEATION; VITRO;
D O I
10.1021/acs.jcim.3c00951
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Peptides that pass through the blood-brain barrier (BBB) not only are implicated in brain-related pathologies but also are promising therapeutic tools for treating brain diseases, e.g., as shuttles carrying active medicines across the BBB. Computational prediction of BBB-penetrating peptides (B3PPs) has emerged as an interesting approach because of its ability to screen large peptide libraries in a cost-effective manner. In this study, we present BrainPepPass, a machine learning (ML) framework that utilizes supervised manifold dimensionality reduction and extreme gradient boosting (XGB) algorithms to predict natural and chemically modified B3PPs. The results indicate that the proposed tool outperforms other classifiers, with average accuracies exceeding 94% and 98% in 10-fold cross-validation and leave-one-out cross-validation (LOOCV), respectively. In addition, accuracy values ranging from 45% to 97.05% were achieved in the independent tests. The BrainPepPass tool is available in a public repository for academic use (https://github.com/ewerton-cristhian/BrainPepPass).
引用
收藏
页码:2368 / 2382
页数:15
相关论文
共 50 条
[31]   The effects of gold nanoparticles functionalized with β-amyloid specific peptides on an in vitro model of blood-brain barrier [J].
Ruff, J. ;
Huewel, S. ;
Kogan, Marcelo J. ;
Simon, Ulrich ;
Galla, Hans-Joachim .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2017, 13 (05) :1645-1652
[32]   A Classification-Based Blood-Brain Barrier Model: A Comparative Approach [J].
Saber, Ralph ;
Rihana, Sandy .
PHARMACEUTICALS, 2025, 18 (06)
[33]   Nanomedicine based strategies for oligonucleotide traversion across the blood-brain barrier [J].
Amulya, Etikala ;
Sikder, Anupama ;
Vambhurkar, Ganesh ;
Shah, Saurabh ;
Khatri, Dharmendra Kumar ;
Raghuvanshi, Rajeev Singh ;
Singh, Shashi Bala ;
Srivastava, Saurabh .
JOURNAL OF CONTROLLED RELEASE, 2023, 354 :554-571
[34]   The potential for nanoparticle-based drug delivery to the brain: overcoming the blood-brain barrier [J].
Barbu, Eugen ;
Molnar, Eva ;
Tsibouklis, John ;
Gorecki, Dariusz C. .
EXPERT OPINION ON DRUG DELIVERY, 2009, 6 (06) :553-565
[35]   Manganese nanoparticles induce blood-brain barrier disruption, cerebral blood flow reduction, edema formation and brain pathology associated with cognitive and motor dysfunctions [J].
Sharma, Aruna ;
Feng, Lianyuan ;
Muresanu, Dafin F. ;
Sahib, Seaab ;
Tian, Z. Ryan ;
Vicente Lafuente, Jose ;
Buzoianu, Anca D. ;
Castellani, Rudy J. ;
Nozari, Ala ;
Wiklund, Lars ;
Sharma, Hari Shanker .
NANOMEDICINE AND NEUROPROTECTION IN BRAIN DISEASES, 2021, 265 :385-406
[36]   Penetrating the Blood-Brain Barrier with New Peptide-Porphyrin Conjugates Having anti-HIV Activity [J].
Mendonca, Diogo A. ;
Bakker, Mariet ;
Cruz-Oliveira, Christine ;
Neves, Vera ;
Angeles Jimenez, Maria ;
Defaus, Sira ;
Cavaco, Marco ;
Veiga, Ana Salome ;
Cadima-Couto, Iris ;
Castanho, Miguel A. R. B. ;
Andreu, David ;
Todorovski, Toni .
BIOCONJUGATE CHEMISTRY, 2021, 32 (06) :1067-1077
[37]   Identifying blood-brain barrier peptides by using amino acids physicochemical properties and features fusion method [J].
Zou, Hongliang .
PEPTIDE SCIENCE, 2022, 114 (02)
[38]   Open source board based acoustofluidic transwells for reversible disruption of the blood-brain barrier for therapeutic delivery [J].
Wang, Ke ;
Sun, Chao ;
Dumcius, Povilas ;
Zhang, Hongxin ;
Liao, Hanlin ;
Wu, Zhenlin ;
Tian, Liangfei ;
Peng, Wang ;
Fu, Yongqing ;
Wei, Jun ;
Cai, Meng ;
Zhong, Yi ;
Li, Xiaoyu ;
Yang, Xin ;
Cui, Min .
BIOMATERIALS RESEARCH, 2023, 27 (01)
[39]   Targeted Drug Delivery Across Blood-Brain-Barrier Using Cell Penetrating Peptides Tagged Nanoparticles [J].
Malhotra, Meenakshi ;
Prakash, Satya .
CURRENT NANOSCIENCE, 2011, 7 (01) :81-93
[40]   cΔlog kwIAM: can we afford estimation of small molecules' blood-brain barrier passage based upon in silico phospholipophilicity? [J].
Grumetto, Lucia ;
Russo, Giacomo .
ADMET AND DMPK, 2021, 9 (04) :267-281